Albireo pharma q1 loss per share $2.23

Albireo reports q1 2020 financial results and provides business update.q1 loss per share $2.23.q1 revenue $1.5 million versus $600,000.q1 revenue estimate $1 million -- refinitiv ibes data.q1 earnings per share estimate $-1.37 -- refinitiv ibes data.commercial preparations advancing, with topline pedfic 1 results expected mid-2020.fundamentals remain unchanged.continue to make significant progress across development programs.prior guidance regarding clinical trials remains unchanged.
ALBO Ratings Summary
ALBO Quant Ranking